Pharmacy
A full 87 percent of those surveyed listed pharmaceutical and biotech companies as having the biggest impact on the cost of healthcare.
The new collaboration will decrease the error rate for providers and lower costs for health plans, CEO says.
Less than half, 48 percent, of all drug coverage decisions are consistent across the majority of health plans, findings showed.
Of those payments, about $4.7 billion were related to research while $2.8 billion were non-research payments.
Customers pay a monthly service fee, which is often covered by insurance companies and Medicare Part D plans.
The bill, known as the Support for Patients and Communities Act passed the House by a decisive majority of 396 to 14.
One new policy deems drug shortages an urgent public health crisis and seeks to have manufacturing sites deemed critical infrastructure.
A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase their sales growth and margin profile.
Practice of PBMs being financially rewarded by drug manufacturers for setting higher prices needs to end, he says.
Kaiser Permanente found that hospitals can bolster patient satisfaction scores and increase revenue by decreasing levels of opioid prescriptions.